151 related articles for article (PubMed ID: 1861528)
1. Should alpha interferon be used as primary treatment for hairy cell leukemia? Italian Cooperative Group for Hairy Cell Leukemia.
Capnist G; Federico M; Chisesi T; Resegotti L; Pagnucco G; Castoldi GL; Lamparelli T; Frassoldati A; Guarnaccia C; Leoni P
Leuk Res; 1991; 15(6):419-26. PubMed ID: 1861528
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
[TBL] [Abstract][Full Text] [Related]
3. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
Damasio EE; Frassoldati A
Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061
[TBL] [Abstract][Full Text] [Related]
4. Human lymphoblastoid interferon as initial therapy in hairy cell leukaemia: a multicentre study in non-splenectomized patients. Italian Cooperative Group for Hairy Cell Leukemia.
Federico M; Chisesi T; Lauria F; Bernasconi C; Capnist G; Castoldi G; Damasio E; Pagnucco G; Frassoldati A; Resegotti L
Br J Haematol; 1989 May; 72(1):54-6. PubMed ID: 2660901
[TBL] [Abstract][Full Text] [Related]
5. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy after initial therapy with alpha-IFN in patients with hairy-cell leukemia (HCL): a multi-center study by the Italian Cooperative Group for HCL. Preliminary results.
Damasio EE; Federico M; Frassoldati A; Lamparelli T; Annino L; Bernasconi C; Chisesi T; Foá R; Lauria F; Pagnucco G
Eur J Haematol Suppl; 1990; 52():29-31. PubMed ID: 2279542
[TBL] [Abstract][Full Text] [Related]
7. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
[TBL] [Abstract][Full Text] [Related]
8. Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Italian Cooperative Group for Hairy Cell Leukemia.
Frassoldati A; Lamparelli T; Federico M; Annino L; Capnist G; Pagnucco G; Dini E; Resegotti L; Damasio EE; Silingardi V
Leuk Lymphoma; 1994 Apr; 13(3-4):307-16. PubMed ID: 7519510
[TBL] [Abstract][Full Text] [Related]
9. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pentostatin and alpha interferon in splenectomized patients with active hairy cell leukemia: an intergroup study. Cancer and Leukemia Group B and South-West Oncology Group.
Rai KR
Leuk Lymphoma; 1994; 14 Suppl 1():107-8. PubMed ID: 7820040
[TBL] [Abstract][Full Text] [Related]
11. Splenectomy vs. alpha interferon: a randomized study in patients with previously untreated hairy cell leukemia.
Smalley RV; Connors J; Tuttle RL; Anderson S; Robinson W; Whisnant JK
Am J Hematol; 1992 Sep; 41(1):13-8. PubMed ID: 1503094
[TBL] [Abstract][Full Text] [Related]
12. Different antitumor mechanisms of interferon-alpha in the treatment of hairy cell leukemia and renal cell cancer.
Porzsolt F; Digel W; Jacobsen H; Mittnacht S; Kirchner H; Heimpel H
Cancer; 1988 Jan; 61(2):288-93. PubMed ID: 3334965
[TBL] [Abstract][Full Text] [Related]
13. Prognostic variables in hairy cell leukemia after splenectomy as initial therapy.
Ratain MJ; Vardiman JW; Barker CM; Golomb HM
Cancer; 1988 Dec; 62(11):2420-4. PubMed ID: 3179961
[TBL] [Abstract][Full Text] [Related]
14. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
[TBL] [Abstract][Full Text] [Related]
15. Long term results of interferon treatment in hairy cell leukemia. Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL).
Capnist G; Federico M; Chisesi T; Resegotti L; Lamparelli T; Fabris P; Rossi G; Invernizzi R; Guarnaccia C; Leoni P
Leuk Lymphoma; 1994 Aug; 14(5-6):457-64. PubMed ID: 7812205
[TBL] [Abstract][Full Text] [Related]
16. Hairy cell leukemia. A therapeutical update.
Damasio EE; Pagnucco G; Federico M; Annino L; Chisesi T; Lamparelli T; Lauria F; Castoldi G; Resegotti L
Haematologica; 1989; 74(2):205-18. PubMed ID: 2473014
[TBL] [Abstract][Full Text] [Related]
17. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
[TBL] [Abstract][Full Text] [Related]
18. Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: a long-term follow-up analysis.
Damasio EE; Clavio M; Masoudi B; Isaza A; Spriano M; Rossi E; Casciaro S; Cerri R; Risso M; Nati S; Siccardi M; Truini M; Gobbi M
Eur J Haematol; 2000 Jan; 64(1):47-52. PubMed ID: 10680705
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hairy-cell leukemia with recombinant alpha 2-interferon.
Berneman ZN; Gastl G; Gangji D; van Camp B; Jochmans K; Aulitzky W; Flament J; Peetermans ME; Huber C
Eur J Cancer Clin Oncol; 1986 Aug; 22(8):987-90. PubMed ID: 3770055
[TBL] [Abstract][Full Text] [Related]
20. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
